Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...
The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the ...
The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new ...
This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...
Verywell Health on MSN11d
Can a UTI Go Away Without Treatment?
An uncomplicated urinary tracti infection (UTI) could go away on its own, but waiting increases the risk of symptoms turning ...
As I perused the latest edition of Georgetown’s leading publication — the Stall Seat Journal — I was pleased to see a brief ...
Currently, the most common treatment for uncomplicated ... These antibiotics are effective in treating uncomplicated UTIs caused by bacteria like E. coli, but their effectiveness is increasingly ...
The drug chemically known as gepotidacin is designed to target the most common UTI-causing bacteria such as E. coli, the company said. The drug acts on a different part of the bacteria compared to ...
Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...